Robustness of convolutional neural networks in recognition of pigmented skin lesions
- PMID: 33423009
- DOI: 10.1016/j.ejca.2020.11.020
Robustness of convolutional neural networks in recognition of pigmented skin lesions
Abstract
Background: A basic requirement for artificial intelligence (AI)-based image analysis systems, which are to be integrated into clinical practice, is a high robustness. Minor changes in how those images are acquired, for example, during routine skin cancer screening, should not change the diagnosis of such assistance systems.
Objective: To quantify to what extent minor image perturbations affect the convolutional neural network (CNN)-mediated skin lesion classification and to evaluate three possible solutions for this problem (additional data augmentation, test-time augmentation, anti-aliasing).
Methods: We trained three commonly used CNN architectures to differentiate between dermoscopic melanoma and nevus images. Subsequently, their performance and susceptibility to minor changes ('brittleness') was tested on two distinct test sets with multiple images per lesion. For the first set, image changes, such as rotations or zooms, were generated artificially. The second set contained natural changes that stemmed from multiple photographs taken of the same lesions.
Results: All architectures exhibited brittleness on the artificial and natural test set. The three reviewed methods were able to decrease brittleness to varying degrees while still maintaining performance. The observed improvement was greater for the artificial than for the natural test set, where enhancements were minor.
Conclusions: Minor image changes, relatively inconspicuous for humans, can have an effect on the robustness of CNNs differentiating skin lesions. By the methods tested here, this effect can be reduced, but not fully eliminated. Thus, further research to sustain the performance of AI classifiers is needed to facilitate the translation of such systems into the clinic.
Keywords: Artificial intelligence; Deep learning; Dermatology; Machine learning; Melanoma; Neural networks; Nevus; Skin neoplasms.
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Conflict of interest statement Sebastian H. reports advisory roles for or has received honoraria from Pierre Fabre Pharmaceuticals, Novartis, Roche, BMS, Amgen and MSD outside the submitted work. Axel H. reports clinical trial support, speaker's honoraria, or consultancy fees from the following companies: Amgen, BMS, Merck Serono, MSD, Novartis, Oncosec, Philogen, Pierre Fabre, Provectus, Regeneron, Roche, OncoSec, Sanofi-Genzyme, and Sun Pharma, outside, the submitted work. BS reports advisory roles for or has received honoraria from Pierre Fabre Pharmaceuticals, Incyte, Novartis, Roche, BMS and MSD, research funding from BMS, Pierre Fabre Pharmaceuticals and MSD, and travel support from Novartis, Roche, BMS, Pierre Fabre Pharmaceuticals and Amgen; outside the submitted work. JSU is on the advisory board or has received honoraria and travel support from Amgen, Bristol Myers Squibb, GSK, LeoPharma, Merck Sharp and Dohme, Novartis, Pierre Fabre, Roche, outside the submitted work. WS received travel expenses for attending meetings and/or (speaker) honoraria from Abbvie, Almirall, Bristol-Myers Squibb, Celgene, Janssen, LEO Pharma, Lilly, MSD, Novartis, Pfizer, Roche, Sanofi Genzyme and UCB outside the submitted work. FM has received travel support or/and speaker's fees or/and advisor's honoraria by Novartis, Roche, BMS, MSD and Pierre Fabre and research funding from Novartis and Roche. TJB reports owning a company that develops mobile apps (Smart Health Heidelberg GmbH, Handschuhsheimer Landstr. 9/1, 69120 Heidelberg; https://smarthealth.de). The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Association between different scale bars in dermoscopic images and diagnostic performance of a market-approved deep learning convolutional neural network for melanoma recognition.Eur J Cancer. 2021 Mar;145:146-154. doi: 10.1016/j.ejca.2020.12.010. Epub 2021 Jan 16. Eur J Cancer. 2021. PMID: 33465706
-
Skin cancer classification via convolutional neural networks: systematic review of studies involving human experts.Eur J Cancer. 2021 Oct;156:202-216. doi: 10.1016/j.ejca.2021.06.049. Epub 2021 Sep 8. Eur J Cancer. 2021. PMID: 34509059
-
Past and present of computer-assisted dermoscopic diagnosis: performance of a conventional image analyser versus a convolutional neural network in a prospective data set of 1,981 skin lesions.Eur J Cancer. 2020 Aug;135:39-46. doi: 10.1016/j.ejca.2020.04.043. Epub 2020 Jun 10. Eur J Cancer. 2020. PMID: 32534243
-
Systematic outperformance of 112 dermatologists in multiclass skin cancer image classification by convolutional neural networks.Eur J Cancer. 2019 Sep;119:57-65. doi: 10.1016/j.ejca.2019.06.013. Epub 2019 Aug 14. Eur J Cancer. 2019. PMID: 31419752
-
[Computer-assisted skin cancer diagnosis : Is it time for artificial intelligence in clinical practice?].Hautarzt. 2020 Sep;71(9):669-676. doi: 10.1007/s00105-020-04662-8. Hautarzt. 2020. PMID: 32747996 Review. German.
Cited by
-
The role of artificial intelligence and convolutional neural networks in the management of melanoma: a clinical, pathological, and radiological perspective.Melanoma Res. 2024 Apr 1;34(2):96-104. doi: 10.1097/CMR.0000000000000951. Epub 2023 Dec 22. Melanoma Res. 2024. PMID: 38141179 Free PMC article.
-
Computer Aided Diagnosis of Melanoma Using Deep Neural Networks and Game Theory: Application on Dermoscopic Images of Skin Lesions.Int J Mol Sci. 2022 Nov 10;23(22):13838. doi: 10.3390/ijms232213838. Int J Mol Sci. 2022. PMID: 36430315 Free PMC article.
-
Multispectral Imaging Algorithm Predicts Breslow Thickness of Melanoma.J Clin Med. 2021 Dec 30;11(1):189. doi: 10.3390/jcm11010189. J Clin Med. 2021. PMID: 35011930 Free PMC article.
-
Comparison of Convolutional Neural Network Architectures for Robustness Against Common Artefacts in Dermatoscopic Images.Dermatol Pract Concept. 2022 Jul 1;12(3):e2022126. doi: 10.5826/dpc.1203a126. eCollection 2022 Jul. Dermatol Pract Concept. 2022. PMID: 36159141 Free PMC article.
-
iMAGING: a novel automated system for malaria diagnosis by using artificial intelligence tools and a universal low-cost robotized microscope.Front Microbiol. 2023 Nov 24;14:1240936. doi: 10.3389/fmicb.2023.1240936. eCollection 2023. Front Microbiol. 2023. PMID: 38075929 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical